Andrew Rice
-
A rare bacterial protein tweak could point to new antibiotic targets
The biochemistry lab of Doug Mitchell discovered the enzyme responsible for a rare chemical modification that doesn't exist in human cells, which can potentially become a new target for developing antibiotics that selectively kill bacteria without harming our own cells. Read MoreApr. 21, 2026
-
Vanderbilt research looks to smooth out bumps in medicinal chemistry processes
Vanderbilt researchers probe the mysteries of an enzyme that could be used as a tool in basic research and medicinal chemistry. Read MoreSep. 23, 2025